ICMR Bioethics Unit

Other Guidelines, Acts and Reports

Download
2021 ICRIER KAS Policy Brief #1 TRACKING COVID-19. View
2021 WHO R&D Blueprint. COVID-19 WHO Ethics & COVID-19 Working Group Achievements. February 2020 – May 2021 View
2020 National Digital Health Mission: Health Data Management Policy, 2020 View
2020 Draft Regulatory Guidelines for Development of Vaccines with Special Consideration for COVID-19 Vaccine- September 2020 View
2020 Draft GSR 354 E Compassionate use of new drug. New Drugs and Clinical Trials (Amendment) Rules, 2020. View
2020 Dissemination Report on ICMR National Ethical Guidelines View
2019 National Guidelines for Gene Therapy Product Development and Clinical Trials View
2019 Relevant Sections of 'New Drugs and Clinical Trials Rules 2019' pertaining to Biomedical & Health Research View
2019 New Drugs and Clinical Trials Rules 2019 View
2019 Frequently Asked Questions (FAQs) on New Drugs and Clinical Trials Rules 2019 View
2018 University Grants Commission (Promotion of Academic Integrity and Prevention Of Plagiarism in Higher Educational Institutions) Regulations, 2018 View
2018 ICMR Report - "Definition of Terms Used in Limitation of Treatment and Providing Palliative Care at End of Life" View
2017 National Guidelines for Stem Cell Research. Indian Council of Medical Research and Department of Biotechnology View
2017 Hand Book for Applicants and Reviewers of Clinical Trials of New Drugs in India. Indian Council of Medical Research and The Central Drugs Standard Control Organization View
2017 ICMR-WHO Report on Regional and National Consultation for Ethical Guidelines for Biomedical and Health Research View
2017 Regulations and Guidelines for Recombinant DNA Research and Biocontainment. Department of Biotechnology (DBT) View
2016 Accreditation Standards for Ethics Committees. National Accreditation Board for Hospitals & Healthcare Providers (NABH) View
2016 The Drugs & Cosmetics Act, 1940 & Rules, 1945. Amended View